Pediatric Endocrinology, University Children's Hospital Tübingen, Hoppe-Seyler-Street 1, Tübingen, Germany.
Clin Genet. 2012 Apr;81(4):366-77. doi: 10.1111/j.1399-0004.2012.01844.x. Epub 2012 Feb 8.
Almost half of the patients with Silver-Russell syndrome (SRS) are affected by DNA hypomethylation of the Imprinting Center Region 1 (ICR1) at the IGF2/H19 locus on 11p15. We searched genome-wide for additional aberrant DNA methylation in such SRS patients that could account for the clinical variability of the disorder. For this purpose, 18 children with SRS (11 with ICR1 hypomethylation) and 9 children small for gestational age (SGA), serving as controls, were recruited. Genomic DNA from whole blood was subjected to microarray analysis with the HumanMethylation27 BeadChip. This array allows investigating 27,500 CpG sites mostly located in the promoter regions of 14,000 genes. Data were validated by the methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) technique for the 11p15 region. SRS patients with ICR1 hypomethylation were significantly more frequently affected by DNA hypo- and hypermethylation of CpG sites from diverse imprinted loci than the SGA controls (p = 0.0048). There was no recurrent specific methylation defect outside of IGF2/H19. These findings suggest as causative in SRS a defective mechanism necessary for establishment or maintenance of imprinting marks, which affects imprinted loci in general with low specificity and the IGF2/H19 locus with high specificity, implying the existence of some structural peculiarities at the IGF2/H19 locus.
大约一半的 Silver-Russell 综合征(SRS)患者受到 11p15 上 IGF2/H19 基因座印迹中心区域 1(ICR1)的 DNA 低甲基化的影响。我们在这些 SRS 患者中搜索了全基因组范围内的其他异常 DNA 甲基化,以解释该疾病的临床变异性。为此,招募了 18 名患有 SRS(11 名 ICR1 低甲基化)的儿童和 9 名因宫内发育迟缓(SGA)而身材矮小的儿童作为对照组。从全血基因组 DNA 进行了人类甲基化 27 点芯片分析。该芯片允许调查 27500 个 CpG 位点,这些位点主要位于 14000 个基因的启动子区域。数据通过甲基化特异性多重连接依赖性探针扩增(MS-MLPA)技术对 11p15 区域进行了验证。与 SGA 对照组相比,ICR1 低甲基化的 SRS 患者受到来自不同印迹基因座的 CpG 位点的 DNA 低甲基化和高甲基化的影响明显更为频繁(p = 0.0048)。在 IGF2/H19 之外没有反复出现特定的甲基化缺陷。这些发现表明,在 SRS 中,一种建立或维持印记标记所必需的有缺陷的机制是致病原因,该机制通常以低特异性影响印记基因座,以高特异性影响 IGF2/H19 基因座,这意味着 IGF2/H19 基因座存在一些结构特殊性。